ADAPTIMMUNE THERAPEUTICS PLC
Ownership & governance
Executives 3Directors 3Avg age 57Avg tenure 3.2y
CH
Christopher Hill
Chief Executive Officer
Age 46Since 2025-11-13Profile →
+5
Executives3
Board of directors3
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Adrian Rawcliffe | 0.0167 % | 44,327 |
| Goldman Sachs Asset Management International | 0.00247 % | 6,547 |
| Lindbrook Capital LLC | 0.001739 % | 4,610 |
| RhumbLine Advisers LP | 0.001381 % | 3,661 |
| Raiffeisen Capital Asset Management Co. LLC | 0.000342 % | 907 |
Catalog · 2026-07-09
Registry officers6
| Name | Role | Since | Shares |
|---|---|---|---|
| Christopher Hill | Chief Executive Officer | 2025-11-13 | - |
| Lawrence Alleva | Chairman | 2025-11-13 | - |
| Christopher Hill | Director/Board Member | 2025-11-13 | - |
| Garry Menzel | Director/Board Member | 2023-05-31 | - |
| Juli P. Miller | Investor Relations Contact | 2016-07-31 | - |
| Phil Bassett | Corporate Officer/Principal | — | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
Broker actions4
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Downgrade | Neutral | — | 2025-07-29 |
| Mizuho | Downgrade | Neutral | 0.5 | 2025-06-26 |
| Barclays | Maintained | Underweight | 0.46 | 2025-05-14 |
| Wells Fargo | Maintained | Equal-Weight | 1 | 2025-05-14 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.